Hypoadiponectinemia is closely associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects

Metabolic Syndrome and Related Disorders

Volumn 8, Issue 5, 2010, Pages 459-463

  Kashyap, Sangeeta R ^a   Roman, Linda J ^b   Mandarino, Lawrence ^b   Defronzo, Ralph ^b   Bajaj, Mandeep ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; NITRIC OXIDE SYNTHASE; SULFONYLUREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SKELETAL MUSCLE;

ADIPONECTIN; ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TIME FACTORS;

EID: 77958131920     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2010.0018     Document Type: Article

References (30)

1. Bajaj M, Ben-Yehuda O. A big fat wedding: Association of adiponectin with coronary vascular lesions. J Am Coll Cardiol 2006;48:1163-1165.
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miya-gawa J, Hota K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi Y, Matsuzawa Y Paradoxical decrease of an adipose-specific protein, adipo-nectin, in obesity. Biochem Biophys Res Commun 1999;257: 79-83.
3. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
4. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T. Dis¬ruption of adiponectin causes insulin resistance and neoin-timal formation. J Biol Chem 2002;277:25863-25866.
5. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004;291:1730-1737.
6. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004;89:2563-2568.
7. Ouchi N, Kihara S, AritaY, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yama-shita S, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 1999;100:2473-2476.
8. Wang Y, Lam KD, Xu JY, Lu G, Xu LY, Cooper GJ, Xu A. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 2005;18:18341-18347.
9. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Oh-moto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Adiponectin, an adipocyte-derived plasma protein, in¬hibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000;102:1296-1301.
10. Hsueh WA, Quinones MJ, Creager MA. 1997 Endothelium in insulin resistance and diabetes. Diabetes Rev 1997;5:343-352.
11. Cannon R. 1998 Role of nitric oxide in cardiovascular disease: Focus on the endothelium. Clin Chem 1998;44:1809-1819.
12. Michel T, Feron O 1997 Nitric oxide synthases: Which, where, how and why? J Clin Invest 1997;100:2146-2152.
13. Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thoren B, Scherrer U. Insulin resistance, hyperlipemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001; 104:342-345.
14. Shankar R, Wu Y, Shen H, Zhu J, Baron A. Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 2000;49:684-687.
15. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with en-dothelial dysfunction. J Clin Invest 1996;97:2601-2610.
16. Steinberg HO, Brechtel G, Johnson A. Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: A novel action of insulin to increase nitric oxide release. J Clin Invest 1994;94:1172-1179.
17. Kashyap SR, Roman LJ, Lamont J, Masters BS, Bajaj M, Suraamornkul S, Belfort R, Berria R, Kellogg DL Jr, Liu Y, DeFronzo RA. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. J Clin Endocrinol Metab 2005;90:1100-1105.
18. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003;278:45021-45026.
19. Hattori Y, Suzuki M, Hattori S, Kasai K. Globular adipo-nectin upregulates nitric oxide production in vascular en-dothelial cells. Diabetologia 2003;46:1543-1549.
20. Towbin H, Staehelin J, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4354.
21. Steele R, Wall J, DeBodo R, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 1956;187:15-24.
22. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle flow in obese men. J Clin Invest 1990;85:1844-1852.
23. Chen Z.-P, Mitchelhill KI, Michell BJ, Stapleton D, Rodriquez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 1999; 443:285-289.
24. Fulton D, Gratton J.-P, McCabe T.J, Fontana J, Fujio, Y, Walsh K, Franke T.F, Papapetropoulos A, Sessa WC. Reg¬ulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999;399:597-601.
25. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000;101:1539-1545.
26. Jiang Z, Lin Y-W, Clermont A, Igarashi M, King G. Direct demonstration of selective insulin resistance on PI 3 kinase pathway in vascular tissues of obese Zucker (fa/fa) rats. Diabetes 1997;46:54A.
27. Roy D, Perreault M, Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol Endo Metab 1998;274: E692-E699.
28. Williams IL, Wheatcroft SB, Shah AM, Kearney MT. Obesity, atherosclerosis and the vascular endothelium: Mechanisms of reduced nitric oxide bioavailability in obese humans. Int J Obes 2002;26:754-764.
29. Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, Lam KS. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 2004;89:765-769.
30. Hattori S, Hattori Y, Kasai K. Hypoadiponectinemia is caused by chronic blockade of nitric oxide synthesis in rats. Metabolism 2005;54:482-487.